000 01506 a2200421 4500
005 20250515022745.0
264 0 _c20060501
008 200605s 0 0 eng d
022 _a1871-5303
024 7 _a10.2174/187153006776056657
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aVerrotti, Alberto
245 0 0 _aRecent advances on neural tube defects with special reference to Valproic Acid.
_h[electronic resource]
260 _bEndocrine, metabolic & immune disorders drug targets
_cMar 2006
300 _a25-31 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAdult
650 0 4 _aAnimals
650 0 4 _aAnticonvulsants
_xadverse effects
650 0 4 _aEpilepsy
_xclassification
650 0 4 _aEpoxide Hydrolases
_xdeficiency
650 0 4 _aFemale
650 0 4 _aFolic Acid
_xmetabolism
650 0 4 _aFolic Acid Deficiency
_xchemically induced
650 0 4 _aFree Radical Scavengers
_xpharmacology
650 0 4 _aHumans
650 0 4 _aNeural Tube Defects
_xchemically induced
650 0 4 _aPregnancy
650 0 4 _aReperfusion Injury
_xpathology
650 0 4 _aTeratogens
650 0 4 _aValproic Acid
_xadverse effects
700 1 _aTana, Marianna
700 1 _aPelliccia, Piernicola
700 1 _aChiarelli, Francesco
700 1 _aLatini, Giuseppe
773 0 _tEndocrine, metabolic & immune disorders drug targets
_gvol. 6
_gno. 1
_gp. 25-31
856 4 0 _uhttps://doi.org/10.2174/187153006776056657
_zAvailable from publisher's website
999 _c16216194
_d16216194